Search

everythinglearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Alefacept does not effectively treat severe alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Abatacept may help some people with alopecia areata regrow hair.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The higher dose supplement was more effective in treating female hair loss.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Abrocitinib may effectively treat stubborn alopecia universalis.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Baricitinib works better than methotrexate for severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.